'Viagra' for females: Exploring Over-the-Counter Alternatives and Current Treatments
Low sexual desire can affect many women, leading to feelings of frustration and helplessness. In recent years, the term "female Viagra" has emerged in discussions surrounding treatments for low libido in women. While the famous medication Viagra is not FDA-approved for use in females, there are two medications that have received approval specifically for addressing female sexual interest/arousal disorder (FSIAD): Vyleesi (bremelanotide) and Addyi (flibanserin).
This comprehensive article will delve deeper into the details of these FDA-approved medications, including how they function, their potential side effects, and alternative over-the-counter options that some women may consider in a quest to enhance sexual desire.
Understanding Female Sexual Interest/Arousal Disorder (FSIAD)
FSIAD is characterized by a persistent or recurrent lack of sexual desire that causes significant distress or interpersonal difficulties. The factors contributing to low libido can be complex and may involve psychological, relational, or physical elements. Various conditions such as stress, anxiety, hormonal imbalances, and certain medications can all play a significant role in this disorder, emphasizing the need for a nuanced understanding of the issue.
FDA-Approved Treatments: Vyleesi and Addyi
The FDA has approved two key medications for treating FSIAD in premenopausal women, each offering distinct mechanisms of action and methods of administration. Their approval marks a significant advancement in recognizing and addressing women's sexual health issues.
Addyi (Flibanserin)
Addyi was the first drug approved for treating FSIAD and is specifically designed for premenopausal women. It is administered as a daily oral tablet, making it a convenient option for daily use.
Dosage is critical: it should be taken at bedtime to mitigate risks associated with its side effects, which include:
- drowsiness
- dizziness
- nausea
- fatigue
- insomnia
Users may notice a boost in sexual desire over time, with effects potentially taking up to 8 weeks to manifest, although some may experience changes sooner.
Vyleesi (Bremelanotide)
Vyleesi sets itself apart by being an injectable medication. Patients self-administer it via a subcutaneous injection into the thigh or stomach at least 45 minutes before engaging in sexual activity. The effects can last for up to 24 hours, but adherence to the guideline of no more than eight doses per month is crucial for safety.
Possible side effects associated with Vyleesi include:
- nausea and vomiting
- flushing or hot flashes
- irritation at the injection site
- headache
- darkening of the skin
Comparing Addyi and Vyleesi
Here is a detailed comparison of key aspects of Addyi and Vyleesi:
| Feature | Addyi | Vyleesi |
|---|---|---|
| Administration | Daily oral pill | Subcutaneous injection |
| Onset of Action | Up to 8 weeks | 45 minutes |
| Duration | Varies, up to 11 hours | Up to 24 hours |
Why Viagra is Not an Option for Women
Viagra (sildenafil) is not FDA-approved for female use, primarily because its mechanism is specifically designed to enhance blood flow to the penis in males. While some health professionals may prescribe Viagra off-label for women facing specific situations, research regarding its efficacy remains limited and inconclusive.
Viagra operates by blocking the enzyme phosphodiesterase type 5 (PDE-5), which prevents blood flow to the penis from being reduced during an erection. In contrast, female sexual arousal involves a more intricate interplay of emotional and physical factors, rendering Viagra unsuitable as a “one-size-fits-all” solution for women.
Seeking Over-the-Counter Alternatives
Some women actively seek over-the-counter options marketed as libido enhancers. However, it is important to note that the FDA warns against unsanctioned supplements that promise to boost sexual desire—these products may contain unlisted ingredients or potentially harmful substances.
Consulting a healthcare professional is strongly recommended before trying any over-the-counter supplements or medications aimed at improving libido. A healthcare provider can offer critical insights and guidance on the safest and most effective treatment options available, tailored to individual needs and circumstances.
Conclusion
While the term "female Viagra" is commonly used, effective and viable treatments for low libido in women exist in the form of FDA-approved medications like Addyi and Vyleesi. Each of these medications possesses unique mechanisms of action, potential side effects, and methods of administration. Women experiencing low sexual desire should strongly consider consulting a healthcare provider to explore appropriate treatment options that are tailored to their specific needs and situations.
Prioritizing safety and efficacy is crucial when considering treatments for FSIAD or low libido. It is important to be aware that over-the-counter options may not be reliable or effective, and professional guidance can lead to better therapeutic outcomes.